Tick-Borne Encephalitis (TBE): From Tick to Pathology

Area of Science:

• Neurology
• Infectious Diseases
• Virology

Background:

• Tick-borne encephalitis (TBE) is a significant neurological disease caused by the TBE virus (Orthoflavivirus encephalitidis), endemic across Europe and Asia.
• The condition often results in severe neurological involvement and long-term post-encephalitis syndrome, impacting patient morbidity.
• TBE's incidence is rising, with evolving epidemiology linked to global warming and new transmission foci.

Purpose of the Study:

• To provide a comprehensive review of TBE, covering its symptomatology, diagnostics, treatment, and prevention strategies.
• To highlight the current gaps in understanding TBE pathogenesis and the need for improved clinical management.
• To inform healthcare professionals about the increasing threat and evolving epidemiology of TBE.

Main Methods:

• Review of existing literature on TBE pathogenesis, transmission, clinical presentation, and management.
• Analysis of factors influencing TBE disease phenotype, including viral strain, host immune response, and age.
• Exploration of current and potential therapeutic interventions, including antivirals and monoclonal antibodies.

Main Results:

• TBE pathogenesis is not fully understood, influenced by transmission routes, viral factors, and host characteristics.
• The disease can lead to severe neurological complications and long-term morbidity in a substantial percentage of cases.
• Current understanding necessitates further research into diagnostics, treatment, and prevention.

Conclusions:

• A comprehensive understanding of TBE symptomatology, diagnostics, treatment, and prevention is crucial for healthcare professionals.
• There is an urgent need for robust surveillance data and randomized controlled trials for effective TBE management.
• Improving the management and outcomes of TBE requires further research into novel therapeutic agents and strategies.